Activity of eribulin in patients with advanced liposarcoma demonstrated in a subgroup analysis from a randomized phase III study of eribulin versus dacarbazine
Journal of Clinical Oncology Oct 28, 2017
Demetri GD et al. -It has been reported that eribulin with dacarbazine improves OS in patients with advanced liposarcoma (LPS) or leiomyosarcoma. In the current study it was shown that patients with previously treated LPS, eribulin led to superior OS and PFS compared with dacarbazine.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
